FDA Inspection
Sharp Drugs, Inc.Sharp Drugs, Inc. – FDA Inspection, Jul 13, 2018
Record Details
This FDA Inspection record concerns Sharp Drugs, Inc., with an inspection on July 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6234fcb3-51fd-41f9-8011-96f37b8a2c01
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1060054
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sharp Drugs, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 6, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sharp Drugs, Inc.
- FDA Inspection 1167411 - 2022-04-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.